A novel and potent FLT3 and IRAK4 dual inhibitor for the treatment of acute myeloid leukemia

被引：1
|
作者：
Yang, Rui
Wu, Lei
Zhang, Bing
Xiang, Michael
Wang, Suyue
Xiang, Camille
Lu, Zhijian
Xiang, Jason
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-4492
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4492
引用
收藏
页数：2
相关论文
共 50 条
  • [1] FLT3 and IRAK4 Inhibitor Emavusertib in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia
    Seipel, Katja
    Mandhair, Harpreet
    Bacher, Ulrike
    Pabst, Thomas
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (04) : 2946 - 2960
  • [2] Correction to: Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia
    Juanjuan Zhao
    Yongping Song
    Delong Liu
    Biomarker Research, 7
  • [3] Discovery of SILA-123 as a Highly Potent FLT3 Inhibitor for the Treatment of Acute Myeloid Leukemia with Various FLT3 Mutations
    Wei, Tian-Hua
    Wang, Zi-Xuan
    Lu, Meng-Yi
    Xu, Yu-Jing
    Yang, Jin
    Ni, Xing-Feng
    Cheng, Yang
    Zhang, Meng-Yuan
    Liu, Jia-Chuan
    Li, Qing-Qing
    Cai, Jiao
    Chen, Zi-Jun
    Kang, Ji-Bo
    Li, Nan
    Dai, Wei-Chen
    Ding, Ning
    Yu, Yan-Cheng
    Leng, Xue-Jiao
    Xue, Xin
    Wang, Xiao-Long
    Sun, Shan-Liang
    Yang, Ye
    Li, Nian-Guang
    Shi, Zhi-Hao
    JOURNAL OF MEDICINAL CHEMISTRY, 2024,
  • [4] AMG 925 Is a Dual FLT3/CDK4 Inhibitor with the Potential to Overcome FLT3 Inhibitor Resistance in Acute Myeloid Leukemia
    Li, Cong
    Liu, Liqin
    Liang, Lingming
    Xia, Zhen
    Li, Zhihong
    Wang, Xianghong
    McGee, Lawrence R.
    Newhall, Katie
    Sinclair, Angus
    Kamb, Alexander
    Wickramasinghe, Dineli
    Dai, Kang
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (02) : 375 - 383
  • [5] Antitumor activity of the potent and novel FLT3 inhibitor HM43239 in acute myeloid leukemia
    Lee, Miyoung
    Ha, Young Eun
    Moon, Mi Jin
    Byun, Joo-Yun
    Yu, HyunKyung
    Kang, SeokJong
    Lee, Jaeho
    Lee, Kyuhang
    Kim, Eunkyung
    Kim, Eunyoung
    Lee, Ho Jeong
    Kim, YoungHoon
    Ahn, YoungGil
    Suh, KweeHyun
    Kim, Sun-Jin
    CANCER RESEARCH, 2018, 78 (13)
  • [6] Pacritinib, a Dual FLT3/JAK2 Inhibitor, Reduces Irak-1 Signaling in Acute Myeloid Leukemia
    Cleary, Megan M.
    Thompson, Rhese
    Mahmood, Shawn
    Davare, Monika
    Kurtz, Steve
    Elferich, Johannes
    Shinde, Ujwal
    Druker, Brian J.
    Singer, Jack
    Agarwal, Anupriya
    BLOOD, 2015, 126 (23)
  • [7] Novel targeted therapy for acute myeloid leukemia with a dual FLT3 and JAK2 inhibitor
    Lou, Yin-jun
    ACTA PHARMACOLOGICA SINICA, 2012, 33 (02) : 212 - 213
  • [8] Novel targeted therapy for acute myeloid leukemia with a dual FLT3 and JAK2 inhibitor
    Yin-jun Lou
    Acta Pharmacologica Sinica, 2012, 33 : 212 - 213
  • [9] PLM-101 is a novel and potent FLT3/RET inhibitor with less adverse effects in the treatment of acute myeloid leukemia
    Choi, Yong June
    Park, Jaewoo
    Choi, Hyoyi
    Oh, Su-Jin
    Park, Jin-Hee
    Park, Miso
    Kim, Ji Won
    Kim, Yoon-Gyoon
    Kim, Yong-Chul
    Kim, Myung Jin
    Kang, Keon Wook
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 165
  • [10] GNF-7, a novel FLT3 inhibitor, overcomes drug resistance for the treatment of FLT3‑ITD acute myeloid leukemia
    Xinhua Xiao
    Peihong Wang
    Weina Zhang
    Jiayi Wang
    Mansi Cai
    Hua Jiang
    Yingli Wu
    Huizhuang Shan
    Cancer Cell International, 23
12345